TrademarkDir
RESQ PHARMA
DEAD

Serial Number

97403524

Owner

ResQ Pharma, Inc.

Attorney

HILLARY E MAYNARD

First Use Date

Jul 24, 2017

Filing Date

May 10, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RESQ PHARMA Trademark

Serial Number: 97403524

RESQ PHARMA is a trademark filed by ResQ Pharma, Inc. on May 10, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ResQ Pharma, Inc. (4 trademarks)

242 W. Harrison St., Suite 201
Chicago, IL 60612

Entity Type: 03

Trademark Details

Filing Date

May 10, 2022

Registration Date

Not Registered

First Use Anywhere

July 24, 2017

First Use in Commerce

July 24, 2017

Goods & Services

Research and development of treatments for Local Anesthetic Systemic Toxicity, Non-Opioid Drug Overdose, and Ischemic Reperfusion Injury

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jan 2, 2025 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Dec 27, 2024 ABN3
EXPARTE APPEAL TERMINATED
Dec 27, 2024 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Nov 14, 2024 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
May 6, 2024 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
May 6, 2024 GECD
ACTION CONTINUING FINAL - COMPLETED
May 6, 2024 CNCF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 16, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Feb 16, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 16, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Feb 16, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 16, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 16, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 21, 2023 GNFN
FINAL REFUSAL E-MAILED
Aug 21, 2023 GNFR
FINAL REFUSAL WRITTEN
Aug 21, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2023 CNRT
EXAMINER'S AMENDMENT ENTERED
Apr 7, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 7, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 7, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 7, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2022 NWOS
NEW APPLICATION ENTERED
May 13, 2022 NWAP

Related Trademarks

More from this Owner

RESQ PHARMA

RESQ PHARMA

RESQ PHARMA

RESQ PHARMA

LIPIDRESCUE

LIPIDRESCUE

LIPIDRESCUE

LIPIDRESCUE

LIPIDRESCUE

LIPIDRESCUE